Sensitivity of human immunodeficiency virus infection to various α, β and γ chemokines

References

1. Adams D. H., Lloyd A. R. 1997; Chemokines: leucocyte recruitment and A activation cytokines. Lancet 349:490–495
   [Google Scholar]
2. Barker E., Mackewicz C. E., Reyes-Teran G., Sato A., Stranford S. A., Fujimura S. H., Christopherson C., Chang S. Y., Levy J. A. 1998; Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared to those who have progressed to acquired immunodeficiency syndrome. Blood 92:1–11
   [Google Scholar]
3. Berger E. A. 1997; HIV entry and tropism: the chemokine receptor connection. AIDS 11:3–16
   [Google Scholar]
4. Cocchi F., DeVico A. L., Garzino-Demo A., Arya S. K., Gallo R. C., Lusso P. 1995; Identification of RANTES, MIP-1alpha, and MIP-1beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811–1815
   [Google Scholar]
5. Dolei A., Biolchini A., Serra C., Curreli S., Gomes E., Dianzani F. 1998; Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP-1β and RANTES β-chemokines. AIDS 12:183–190
   [Google Scholar]
6. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. 1996; HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872–877
   [Google Scholar]
7. Frade J. M. R., Llorente M., Mellado M., Alcami J., Gutierrez-Ramos J. C., Zaballos A., del Real G., Martinez-A C. 1997; The amino-terminal domain of the CCR2 chemokine receptor acts as a coreceptor for HIV-1 infection. Journal of Clinical Investigation 100:497–502
   [Google Scholar]
8. Gong W., Howard O. M., Turpin J. A., Grimm M. C., Ueda H., Gray P. W., Raport C. J., Oppenheim J. J., Wang J. M. 1998; Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication. Journal of Biological Chemistry 273:4289–4292
   [Google Scholar]
9. Hoffman A. D., Banapour B., Levy J. A. 1985; Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326–335
   [Google Scholar]
10. Kinter A., Catanzaro A., Monaco J., Ruiz M., Justement J., Moir S., Arthos J., Oliva A., Ehler L., Mizell S., Jackson R., Ostrowski M., Hoxie J., Offord R., Fauci A. S. 1998; CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+)T cells: role of signal transduction. Proceedings of the National Academy of Sciences USA 95:11880–11885
    [Google Scholar]
11. Landay A. L., Mackewicz C., Levy J. A. 1993; An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clinical Immunology and Immunopathology 69:106–116
    [Google Scholar]
12. Lee B., Doranz B. J., Rana S., Yi Y., Mellado M., Frade J. M., Martinez-A C., O’Brien S. J., Dean J., Collman R. G., Doms R. W. 1998; Influence of the CCR2-V641 polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. Journal of Virology 72:7450–7458
    [Google Scholar]
13. Levy J. A., Hoffman A. D., Kramer S. M., Landis J. A., Shimabukuro J. M., Oshiro L. S. 1984; Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225:840–842
    [Google Scholar]
14. McDougal J. S., Cort S. P., Kennedy M. S., Cabridilla C. D., Feorino P. M., Francis D. P., Hicks D., Kalyanaraman V. S., Martin L. S. 1985; Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV. Journal of Immunological Methods 76:171–183
    [Google Scholar]
15. Mackewicz C. E., Ortega H. W., Levy J. A. 1991; CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. Journal of Clinical Investigation 87:1462–1466
    [Google Scholar]
16. Mackewicz C. E., Barker E., Levy J. A. 1996; Role of β-chemokines in suppressing HIV replication. Science 274:1393–1395
    [Google Scholar]
17. Pal R., Garzino-Demo A., Markham P. D., Murns J., Brown M., Gallo R. C., DeVico A. L. 1997; Inhibition of HIV-1 infection by β-chemokine MDC. Science 278:695–698
    [Google Scholar]
18. Rucker J., Samson M., Doranz B. J., Libert F., Berson J. F., Yi Y., Smyth R. J., Collman R. G., Broder C. C., Vassart G., Doms R. W., Parmentier M. 1996; Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87:437–446
    [Google Scholar]
19. Schols D., Proost P., Van Damme J., De Clercq E. 1997; RANTES and MCP-3 inhibit the replication of T-cell-tropic human immunodeficiency virus type 1 strains (SF-2, MN, and HE. Journal of Virology 71:7300–7304
    [Google Scholar]
20. Trkola A., Paxton W. A., Monard S. P., Hoxie J. A., Siani M. A., Thompson D. A., Wu L., Mackay C. R., Horuk R., Moore J. P. 1998; Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. Journal of Virology 72:396–404
    [Google Scholar]
21. Yoshida R., Nagira M., Kitaura M., Imagawa N., Imai T., Yoshie O. 1998; Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. Journal of Biological Chemistry 273:7118–7122
    [Google Scholar]